Back

4D Molecular Therapeutics Quote, Financials, Valuation and Earnings

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).

Sell

FDMT
4D Molecular Therapeutics

Last Price:

25.96

Seasonality Move:

-0.46%

7 Day Trial

ALL ACCESS PASS

$ 7

The little-known AI stock you need to read about now...

Get the name - FREE.

4D Molecular Therapeutics Price Quote

$25.96

+0.39 (+1.53%)

(Updated: May 14, 2024 at 11:20 AM ET)

4D Molecular Therapeutics Key Stats

Sell

4D Molecular Therapeutics (FDMT) is a Sell

Day range:

$25.20 - $27.36

52-week range:

$9.44 - $36.25

Dividend yield:

P/E ratio:

0.00

P/S ratio:

53.99

P/B ratio:

2.2%

Volume:

584.7K

Avg. volume:

520.9K

1-year change:

42.77%

Market cap:

$1.3B

Revenue:

$20.7M

EPS:

$-2.44

How Much Does 4D Molecular Therapeutics Make?

How Much Are 4D Molecular Therapeutics's Sales Annually?
FDMT Revenues are $20.7M
How Much Profit Does 4D Molecular Therapeutics's Make A Year?
FDMT net income is -$100.8M

Is 4D Molecular Therapeutics Growing As A Company?

What Is 4D Molecular Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.91%
What Is 4D Molecular Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

4D Molecular Therapeutics Stock Price Performance

Did 4D Molecular Therapeutics Stock Go Up Last Month?
4D Molecular Therapeutics share price went down by -2.96% last month
Did FDMT's Share Price Rise Over The Last Year?
FDMT share price rose by 42.77% over the past 1 year

What Is 4D Molecular Therapeutics 52-Week High & Low?

What Is 4D Molecular Therapeutics’s 52-Week High Share Price?
4D Molecular Therapeutics has traded as high as $36.25 over the past 52 weeks
What Is 4D Molecular Therapeutics’s 52-Week Low Share Price?
4D Molecular Therapeutics has traded as low as $9.44 over the past 52 weeks

4D Molecular Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy 4D Molecular Therapeutics?

How Much Debt Does 4D Molecular Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does 4D Molecular Therapeutics Have?
Cash and short term investments quarterly total is $525.9M
What Is 4D Molecular Therapeutics’s Book Value Per Share?
Book value per share is 11.74

Is 4D Molecular Therapeutics Cash Flow Positive?

What Is FDMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$77M
What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $464.7M
What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$190.7M

4D Molecular Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
FDMT return on invested capital is -29.34%
What Is 4D Molecular Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -27.12%
What Is FDMT Return On Equity?
ROE is a measure of profitability and is -29.34%

4D Molecular Therapeutics Earnings Date & Stock Price

What Is 4D Molecular Therapeutics's Stock Price Today?
A single share of FDMT can be purchased today for 25.57
What Is 4D Molecular Therapeutics’s Stock Symbol?
4D Molecular Therapeutics trades on the nasdaq under the ticker symbol: FDMT
When Is 4D Molecular Therapeutics’s Next Earnings Date?
The next quarterly earnings date for 4D Molecular Therapeutics is scheduled on August 9, 2024
When Is FDMT's next ex-dividend date?
4D Molecular Therapeutics's next ex-dividend date is May 14, 2024
How To Buy 4D Molecular Therapeutics Stock?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

4D Molecular Therapeutics Competitors

Who Are 4D Molecular Therapeutics's Competitors?
Below is a list of companies who compete with 4D Molecular Therapeutics or are related in some way:
- iBio Inc (IBIO)
- Ionis Pharmaceuticals Inc (IONS)
- NovaBay Pharmaceuticals Inc (NBY)
- Palatin Technologies Inc (PTN)
- Theriva Biologics Inc (TOVX)

4D Molecular Therapeutics Dividend Yield